146: The Muscle Biology Behind Diabetes Risk

Bikman explains that the metabolic advantage of type 1 fibers is primarily quantitative—they have more copies of the same proteins. By increasing muscle fiber size through resistance training, you increase the total amount of that machinery, even in fast-twitch fibers. This provides more 'sites' for glucose uptake. He contrasts resistance training with endurance exercise, which tends to shift fiber phenotype toward type 1 but does not significantly increase overall muscle mass. He emphasizes that the loss of fast-twitch fibers with age and sedentary behavior is a major blow to glucose disposal capacity, so resistance training is a critical defense. Thus, the protocol is not about achieving a specific fiber-type ratio but about maximizing total muscle mass.

Bikman acknowledges that endurance-type activities—walking, low-intensity cycling, standing—recruit type 1 fibers, which rely on oxidative metabolism and are fatigue-resistant. These fibers become more insulin-responsive and efficient with regular use. However, he warns that endurance exercise does not significantly increase muscle size; it does not produce the hypertrophic effect that expands total glucose-handling machinery. Therefore, he frames aerobic exercise as one part of the strategy, but resistance training as the essential foundation for metabolic health.

Bikman explains that skeletal muscle is not a uniform tissue but a mosaic of fiber types. Type 1 fibers (slow twitch) are densely packed with mitochondria, richly vascularized, and rely on oxidative metabolism—they burn fat, glucose, and ketones efficiently. Type 2 fibers (fast twitch) contract quickly, produce a lot of force, fatigue rapidly, and rely more on glycolytic (non-oxidative) metabolism, especially the type 2X subpopulation. Central to the lecture is the observation that type 1 fibers are more responsive to insulin than type 2 fibers. This is because type 1 fibers carry substantially higher protein levels of the insulin receptor, GLUT4, hexokinase 2, glycogen synthase, and pyruvate dehydrogenase—essentially more molecular machinery at every step from insulin signaling through glucose import, locking in, storage, and mitochondrial oxidation. Insulin-stimulated glucose disposal rates correlate positively with the proportion of type 1 fibers. When researchers compared people with about 60% type 1 to those with about 36% type 1—all healthy, young, with normal fasting glucose and insulin—the lower-type-1 group showed whole-body insulin sensitivity decreased by approximately 50%, a magnitude usually seen in prediabetes. This suggests that fiber composition is a genuine risk factor, not just a consequence of metabolic disease.

Bikman reveals a nuance: when scientists normalize the insulin signaling response per unit of protein, the intrinsic sensitivity of type 1 and type 2 fibers appears closer than originally thought. The main advantage of type 1 fibers is largely quantitative—they just have more of the relevant molecular machinery (receptors, transporters, enzymes). He emphasizes that bigger muscle fibers, regardless of type, hold more total glucose-disposal capacity. Therefore, the better metabolic strategy is not to try to convert type 2 to type 1, but to build more muscle overall, which enlarges fast-twitch fibers and gives them more total protein and glucose-handling infrastructure. This reframes resistance training as a metabolic health tool because it increases the absolute amount of glucose-handling machinery, not because it dramatically shifts fiber type ratios. This argument leads him to strongly advocate resistance training for metabolic health, beyond any body-composition aesthetic.

Bikman reviews muscle biopsy and metabolic data across major ethnic groups in the U.S. and globally. White Europeans (the reference group) show a roughly 50/50 slow-to-fast twitch ratio. Black individuals, especially women, have a higher proportion of glycolytic type 2X fibers and fewer type 1 fibers, correlating with lower fat oxidation and higher insulin resistance at comparable obesity levels. South Asians display a 'thin-fat phenotype' from birth—lower muscle mass and higher truncal fat—and are more insulin resistant despite higher mitochondrial oxidative capacity, underscoring that total muscle quantity (not just quality) matters. East Asians tend to have lower absolute muscle mass and more visceral fat at any given BMI, necessitating lower BMI cutoffs for metabolic risk. Native Americans (e.g., Pima Indians) have very low type 1 fiber proportions and profoundly elevated insulin resistance, with diabetes appearing in young adults. Pacific Islanders have higher muscle mass and bone density but still exhibit extremely high diabetes prevalence, possibly due to more type 2 fibers and a combination of dietary and central adiposity factors, though direct muscle biopsy data are lacking. These patterns suggest muscle fiber composition is a meaningful contributor to ethnic diabetes disparities.

Bikman argues that focusing on converting fibers from type 2 to type 1 may be misguided; the real metabolic win is making fibers bigger. Resistance training increases the size of type 2 fibers, which expands the total amount of insulin receptors, GLUT4, and enzymes in the muscle. Because the difference between fiber types is quantitative, a larger fast-twitch fiber can handle as much glucose as a smaller slow-twitch fiber. He notes that aging preferentially atrophies fast-twitch fibers because people use them less as they become sedentary. Endurance exercise does not substantially increase muscle size—it promotes oxidative adaptations but often leaves an athlete with relatively small muscles. Therefore, to defend the body's glucose disposal capacity across the lifespan, resistance training is essential. This viewpoint places resistance training at the center of a metabolic health strategy, not just for strength or aesthetics.